A carregar...
Cellular-Based Immunotherapies for Patients with Glioblastoma Multiforme
Treatment of patients with glioblastoma multiforme (GBM) remains to be a challenge with a median survival of 14.6 months following diagnosis. Standard treatment options include surgery, radiation therapy, and systemic chemotherapy with temozolomide. Despite the fact that the brain constitutes an imm...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3299309/ https://ncbi.nlm.nih.gov/pubmed/22474481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/764213 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|